Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$35.00
-0.10-0.28%
At close: Sep 18, 5:00 PM EST
$35.00
N/A
After Hours: 6:14 PM EST
Structure Therapeutics Inc (GPCR) Stock Price, Quote, News & History
GPCRNASDAQ
Structure Therapeutics (GPCR) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Structure Therapeutics (GPCR) stock?
You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.
Who are Structure Therapeutics (GPCR) competitors?
Other companies in Structure Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
What is the forecast, or price target, for Structure Therapeutics (GPCR) stock?
Structure Therapeutics has a consensus price target of $98.06.
What is the current price for Structure Therapeutics (GPCR)?
The stock price for Structure Therapeutics (NASDAQ: GPCR) is $35 last updated September 18, 2026 at 6:14 PM EDT.
Does Structure Therapeutics (GPCR) pay a dividend?
There are no upcoming dividends for Structure Therapeutics.
When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?
Structure Therapeutics does not have any upcoming earnings scheduled.
Is Structure Therapeutics (GPCR) going to split?
There is no upcoming split for Structure Therapeutics.
What sector and industry does Structure Therapeutics (GPCR) operate in?
Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
